Owens & Minor (NYSE:OMI) Price Target Lowered to $14.00 at Robert W. Baird

Owens & Minor (NYSE:OMI) had its price objective decreased by equities researchers at Robert W. Baird from $15.00 to $14.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Robert W. Baird’s price objective would suggest a potential upside of 51.70% from the company’s current price.

Several other research analysts also recently weighed in on OMI. Citigroup dropped their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Barclays dropped their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. Finally, UBS Group decreased their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Owens & Minor currently has a consensus rating of “Hold” and an average target price of $18.50.

Owens & Minor Price Performance

OMI opened at $9.23 on Tuesday. The business’s 50-day moving average is $13.77 and its two-hundred day moving average is $14.28. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor has a 1 year low of $8.76 and a 1 year high of $28.35. The firm has a market capitalization of $711.65 million, a PE ratio of -14.20, a price-to-earnings-growth ratio of 0.40 and a beta of 0.48.

Owens & Minor (NYSE:OMI) last announced its earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.01. The company had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. Owens & Minor’s revenue was up 5.0% compared to the same quarter last year. During the same period last year, the firm earned $0.44 earnings per share. Research analysts anticipate that Owens & Minor will post 1.49 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the sale, the chief financial officer now directly owns 130,822 shares of the company’s stock, valued at $1,546,316.04. This represents a 3.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.62% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Owens & Minor

A number of large investors have recently bought and sold shares of the business. Quarry LP raised its stake in shares of Owens & Minor by 290.1% during the 2nd quarter. Quarry LP now owns 2,099 shares of the company’s stock worth $28,000 after buying an additional 1,561 shares during the period. Blue Trust Inc. raised its position in Owens & Minor by 176.8% during the third quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock worth $44,000 after acquiring an additional 1,780 shares during the period. KBC Group NV lifted its holdings in Owens & Minor by 98.2% during the fourth quarter. KBC Group NV now owns 4,434 shares of the company’s stock valued at $58,000 after purchasing an additional 2,197 shares in the last quarter. Meeder Asset Management Inc. grew its position in shares of Owens & Minor by 844.1% in the third quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company’s stock valued at $141,000 after purchasing an additional 8,061 shares during the period. Finally, Marshall Wace LLP increased its stake in shares of Owens & Minor by 38.4% during the second quarter. Marshall Wace LLP now owns 11,100 shares of the company’s stock worth $150,000 after purchasing an additional 3,077 shares in the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.